RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
  Adrenergics
  Analgesics
  Anti Cancer Drugs
  Anti-Clotting Drugs
  Anti-Inflammatory
  Antibiotics
  Anticholesterol
   Simvastatin
   Torceptrapib
  Antihypertensives
  Antivirals
  Fatty Acids
  Hypnotics
  Metals
  PPI
  Surfactants
  Varenicline
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Anticholesterol Channel

subscribe to Anticholesterol newsletter
Latest Research : Pharmacology : Anticholesterol

   EMAIL   |   PRINT
Class Effect of Statins in Elderly Patients

Apr 26, 2005 - 6:55:00 PM
However, evidence supporting this assumption has been limited, and prescribing practice suggest that some statins are preferred over others. Zhou and colleagues compared the effectiveness of 5 commonly prescribed statins in a head-to-head retrospective analysis of data 18 000 elderly patients who had AMI and who filled a prescription for a statin within 90 days after discharge. They found that the 5 statins were equally effective for secondary prevention after AMI.

 
[RxPG] Evidence has shown that the use of statins after acute myocardial infarction (AMI) is effective in reducing the incidence of both fatal and nonfatal cardiovascular events. Since they belong to the same drug class, they are generally thought to be therapeutically equivalent.

However, evidence supporting this assumption has been limited, and prescribing practice suggest that some statins are preferred over others. Zhou and colleagues compared the effectiveness of 5 commonly prescribed statins in a head-to-head retrospective analysis of data 18 000 elderly patients who had AMI and who filled a prescription for a statin within 90 days after discharge. They found that the 5 statins were equally effective for secondary prevention after AMI.

However, the costs of statins differ, as Wright points out in a related commentary, which gives physicians an opportunity to reduce costs to patients and the health care system while still achieving optimal health outcomes for their patients.



Publication: p. 1187 Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect – L. Pilote et al; p. 1195 Are the benefits of statins a class effect? – J.M. Wright
On the web: www.cma.ca/cmaj 

Advertise in this space for $10 per month. Contact us today.


Related Anticholesterol News
NIH clinical trial begins for treatment of rare, fatal neurological disorder
Moderate coffee consumption may reduce risk of diabetes by up to 25 percent
Low vitamin D level is linked to greater chance of risk factors for Type 2 diabetes
Liraglutide with insulin improves poorly controlled Type 1 diabetes
Risk score could lead to better diagnosis of the metabolic syndrome in children
Exercise with diet improves insulin sensitivity much more than diet alone
Moderate drinking associated with lower risk of stroke in women
Psoriasis is associated with impaired HDL function, Penn study finds
NIH stops clinical trial on combination cholesterol treatment
Cholesterol-lowering drug shrinks enlarged prostates in hamster model

Subscribe to Anticholesterol Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)